Share this article

print logo

Medical Campus Innovation Center nearly full

The Thomas R. Beecher Jr. Innovation Center, a hot spot on the Buffalo Niagara Medical Campus, soon will be full.

The 128,000-square-foot center at 640 Ellicott St. has seen consistent growth as a hub on campus for startup companies and entrepreneurs.

Its last remaining chunk of available space on its third floor – with sweeping views of the campus through tall glass windows – will go to tenant ACV Auctions, which continues to expand its presence and has plans to enlarge its office space within the center by spring.

The center has been riding at near capacity for several months. In recent weeks the Medical Campus organization, which owns the building, has been renovating and building out 10,000 square feet of third floor space for ACV Auctions, a rapidly growing 43North business competition winner that already has offices in the center and uses a software platform for online wholesale used car auctions.

The Innovation Center will be fully occupied by the end of this year's first quarter, said Matthew K. Enstice, Medical Campus president and chief executive officer.

Buffalo Niagara Medical Campus president and chief executive officer Matthew Enstice stands in the area of the Innovation Center that is being renovated for ACV Auctions. (Robert Kirkham/Buffalo News)

With the center full, the Medical Campus is shifting its attention on strengthening and expanding its innovation focus to the former Osmose Holdings site on the northern edge of campus by Best and Ellicott streets. Campus leaders are not calling it a second incubator.

"We need to build more space to integrate startups and mature companies," Enstice said, while doing it on the existing footprint of that site and using existing buildings.

Enstice has said the new shift will focus on the private sector and could likely also tap into area universities and colleges, along with long-established companies.

Medical Campus pays $3.8 million for site of new Innovation Center

There are no comments - be the first to comment